ProfileGDS4718 / 225007_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 91% 89% 92% 90% 89% 94% 95% 91% 90% 90% 89% 90% 94% 91% 93% 91% 90% 90% 94% 88% 90% 91% 89% 90% 91% 93% 92% 95% 90% 95% 95% 94% 89% 88% 95% 95% 95% 91% 91% 92% 90% 93% 93% 96% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.4712691
GSM549102patient 115, normal, homogenized [OPG study]8.9452989
GSM549104patient 119, normal, homogenized [OPG study]9.5629292
GSM549108patient 138, normal, homogenized [OPG study]9.0924190
GSM549119patient 077, normal, homogenized [OPG study]9.0378489
GSM549133patient 032, cancer, homogenized [OPG study]9.940394
GSM549139patient 042, cancer, homogenized [OPG study]10.140795
GSM549099patient 107, normal, homogenized [OPG study]9.3026691
GSM549109patient 139, normal, homogenized [OPG study]9.18590
GSM549110patient 046, normal, homogenized [OPG study]9.2245190
GSM549114patient 063, normal, homogenized [OPG study]9.2401889
GSM549122patient 082, normal, homogenized [OPG study]9.2806390
GSM549134patient 033, cancer, homogenized [OPG study]9.968294
GSM549136patient 036, cancer, homogenized [OPG study]9.3781491
GSM549140patient 044, cancer, homogenized [OPG study]9.7750393
GSM549111patient 047, normal, homogenized [OPG study]9.4712891
GSM549113patient 057, normal, homogenized [OPG study]9.2864790
GSM549132patient 031, cancer, homogenized [OPG study]9.1083590
GSM549137patient 038, cancer, homogenized [OPG study]9.9850594
GSM549142patient 047, cancer, homogenized [OPG study]8.501888
GSM549100patient 110, normal, homogenized [OPG study]9.1544890
GSM549107patient 135, normal, homogenized [OPG study]9.4525191
GSM549115patient 068, normal, homogenized [OPG study]9.2386589
GSM549116patient 072, normal, homogenized [OPG study]9.2504190
GSM549120patient 078, normal, homogenized [OPG study]9.3656691
GSM549131patient 030, cancer, homogenized [OPG study]9.8364393
GSM549118patient 074, normal, homogenized [OPG study]9.6922392
GSM549129patient 027, cancer, homogenized [OPG study]10.130695
GSM549123patient 088, normal, homogenized [OPG study]9.3117790
GSM549124patient 006, cancer, homogenized [OPG study]9.9960795
GSM549126patient 015, cancer, homogenized [OPG study]10.018895
GSM549128patient 025, cancer, homogenized [OPG study]9.9270594
GSM549103patient 117, normal, homogenized [OPG study]8.8952689
GSM549117patient 073, normal, homogenized [OPG study]8.9727388
GSM549138patient 041, cancer, homogenized [OPG study]10.298895
GSM549141patient 045, cancer, homogenized [OPG study]10.168595
GSM549130patient 028, cancer, homogenized [OPG study]10.125195
GSM549101patient 111, normal, homogenized [OPG study]9.3514391
GSM549105patient 128, normal, homogenized [OPG study]9.2702491
GSM549106patient 134, normal, homogenized [OPG study]9.7912592
GSM549112patient 048, normal, homogenized [OPG study]9.3331190
GSM549125patient 011, cancer, homogenized [OPG study]9.7197193
GSM549127patient 024, cancer, homogenized [OPG study]9.6955193
GSM549135patient 035, cancer, homogenized [OPG study]10.546396